Table 1 Patient characteristics at inclusion in TIRA-2 and at the ten-year follow-up
N, mean(SD) | Inclusion | 10 years | ||||||
|---|---|---|---|---|---|---|---|---|
Women (N = 16) | Men (N = 15) | Total | p | Women | Men | Total | p | |
Age (years) | 48(10) | 50(10) | 49(10) | 0.69 | - | - | - | |
Educational level N Primary Secondary Higher education | 4 7 5 | 5 8 2 | 9 15 7 | |||||
Co-habitating, partner N (%) | 10 (63%) | 11 (73%) | 21 (68%) | 11 (69%) | 12 (80%) | 23 (74%) | ||
Other diagnoses N (%) | 1 (6%) | 1 (7%) | 2 (6%) | 8 (50%) | 3 (20%) | 11 (35%) | ||
Employed, student N (%) | 15 (94%) | 12 (80%) | 27 (87%) | 6 (38%) | 10 (67%) | 16 (52%) | ||
DMARDs N (%) | 16 (100%) | 14 (93%) | 30 (97%) | 8 (50%) 1 | 11 (73%) 2 | 19 (61%) 3 | ||
DAS28 score | 5.1(1.3) | 4.4(1.2) | 4.8(1.3) | 0.090 | 2.6(1.2) | 2.3(0.9) | 2.5(1.1) | 0.967 |
Grippit Newton | 134(75) | 152(87) | 143(81) | 0.615 | 141(79) | 344(58) | 208(122) | < 0.001* |
Pain intensity VAS mm | 48(25) | 43(23) | 46(24) | 0.589 | 32(27) | 35(33) | 34(30) | 0.882 |
HAQ score | 0.7(0.6) | 0.9(0.5) | 0.8(0.5) | 0.302 | 0.6(0.4) | 0.5(0.4) | 0.5(0.4) | 0.852 |
Number of affected VLA’s | - | - | - | 7(8) | 6(8) | 7(8) |